Apimeds Pharmaceuticals US APUS
NYSE APUS
$4.16 -0.23 (-5.21%)
At close: Aug 20, 2026 · 11:16 AM UTC

Apimeds Pharmaceuticals US (APUS) Assets (2023 - 2025)

Apimeds Pharmaceuticals US's (APUS) quarterly Assets came in at $164.2 million in Q4 2025, up 1257338.43% YoY from N/an in Q4 2024, and up 1674.95% on a QoQ basis from $9.3 million in Q3 2025.

Apimeds Pharmaceuticals US (APUS) Assets (2023 - 2025) Analysis & Trends

Apimeds Pharmaceuticals US (APUS) has 3 years of Assets data on file, last reported at $164.2 million in Q4 2025.

  • Quarterly Assets rose 1257338.43% year-over-year to $164.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $164.2 million (up 1257338.43% YoY) and the FY2025 annual result came in at $164.2 million, up 1257338.43% from the prior year.
  • Assets climbed to $164.2 million in Q4 2025, from $9.3 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $164.2 million in Q4 2025 to a low of $13057.0 in Q4 2024.
  • A 3-year average of $30.8 million and a median of $4.8 million in 2023 frame the typical range for Assets.
  • Annual changes were most pronounced in 2024 — Assets sank 96.91% — and 2025, when it surged 1257338.43%.
  • Tracing APUS's Assets over 3 years: stood at $422076.0 in 2023, then slumped by 96.91% to $13057.0 in 2024, then surged by 1257338.43% to $164.2 million in 2025.
  • The last three Assets figures came in at $164.2 million (Q4 2025), $9.3 million (Q3 2025), and $10.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 43.42 Bn 39.76 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.77 Bn 22.98 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.29 Bn 19.63 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.78 Bn 17.89 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.66 Bn 15.27 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.91 Bn 11.38 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - 6.18 Bn
10 Apimeds Pharmaceuticals US 7.12 Mn 7.12 Mn - 127.62 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 164.18 Mn
Sep 30, 2025 9.25 Mn
Jun 30, 2025 10.55 Mn
Mar 31, 2025 259,904.00
Dec 31, 2024 13,057.00
Dec 31, 2023 422,076.00